Aetna Inc. (AET) President Sells $2,472,527.61 in Stock

Aetna Inc. (NYSE:AET) President Karen S. Lynch sold 15,271 shares of the stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares in the company, valued at approximately $10,404,498.51. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of Aetna Inc. (AET) traded down 0.65% during mid-day trading on Wednesday, reaching $155.03. The company had a trading volume of 1,624,224 shares. The company’s 50-day moving average is $157.50 and its 200 day moving average is $145.70. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $164.52. The stock has a market capitalization of $51.49 billion, a P/E ratio of 34.41 and a beta of 0.53.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. During the same quarter in the previous year, the business earned $2.21 EPS. Aetna’s quarterly revenue was down 2.7% compared to the same quarter last year. Analysts anticipate that Aetna Inc. will post $9.55 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Aetna Inc. (AET) President Sells $2,472,527.61 in Stock” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://sportsperspectives.com/2017/09/20/aetna-inc-aet-president-sells-2472527-61-in-stock.html.

Several hedge funds have recently added to or reduced their stakes in the stock. Guardian Life Insurance Co. of America lifted its stake in shares of Aetna by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after purchasing an additional 9 shares during the last quarter. Concert Wealth Management Inc. lifted its stake in shares of Aetna by 0.4% in the 1st quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock valued at $405,000 after purchasing an additional 14 shares during the last quarter. JNBA Financial Advisors lifted its stake in shares of Aetna by 0.7% in the 1st quarter. JNBA Financial Advisors now owns 3,726 shares of the company’s stock valued at $475,000 after purchasing an additional 27 shares during the last quarter. Financial Architects Inc lifted its stake in shares of Aetna by 1.8% in the 2nd quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock valued at $265,000 after purchasing an additional 31 shares during the last quarter. Finally, Wedbush Securities Inc. lifted its stake in shares of Aetna by 1.4% in the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock valued at $574,000 after purchasing an additional 52 shares during the last quarter. 89.52% of the stock is owned by institutional investors and hedge funds.

A number of brokerages have weighed in on AET. Cantor Fitzgerald reissued an “overweight” rating and set a $175.00 price target (up previously from $150.00) on shares of Aetna in a research note on Wednesday, August 9th. Jefferies Group LLC reissued a “hold” rating and set a $163.00 price target (up previously from $157.00) on shares of Aetna in a research note on Friday, August 4th. Deutsche Bank AG increased their price target on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Royal Bank Of Canada increased their price target on Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research note on Friday, August 4th. Finally, Morgan Stanley began coverage on Aetna in a research note on Tuesday, June 6th. They set an “overweight” rating and a $162.00 price target on the stock. Seven investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. Aetna has an average rating of “Buy” and a consensus price target of $159.04.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply